Insider Stock Trading History of Lampert Mark N


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lampert Mark N since year 2005. The trader's CIK number is 1233840. At the time of this reporting, Lampert Mark N is the of Infinity Pharmaceuticals, Inc. . (stock ticker symbol INFI). See this page for all insider trading activities at Infinity Pharmaceuticals, Inc. .

Note that in the past LAMPERT MARK N also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lampert Mark N since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-03 INFI Infinity Pharmaceuticals, Inc. Buy 946,597 1.24 1,169,047
2017-10-04 INFI Infinity Pharmaceuticals, Inc. Buy 653,449 1.28 839,028
2017-08-15 XENE Xenon Pharmaceuticals Inc. Buy 18,858 2.41 45,485
2017-08-14 XENE Xenon Pharmaceuticals Inc. Buy 41,344 2.70 111,794
2017-07-14 CAPS Orthologic Corp Sale 4,341,586 .06 260,495
2017-06-27 XENE Xenon Pharmaceuticals Inc. Buy 85,461 4.00 341,844
2017-06-22 XENE Xenon Pharmaceuticals Inc. Buy 8,263 4.00 33,052
2017-06-21 XENE Xenon Pharmaceuticals Inc. Buy 12,148 4.00 48,592
2017-06-20 NVLS Nivalis Therapeutics, Inc. Buy 17,806 2.25 40,063
2017-06-15 XENE Xenon Pharmaceuticals Inc. Buy 11,779 3.84 45,196
2017-06-16 XENE Xenon Pharmaceuticals Inc. Buy 11,034 3.85 42,480
2017-06-19 XENE Xenon Pharmaceuticals Inc. Buy 3,595 3.85 13,840
2017-06-06 XENE Xenon Pharmaceuticals Inc. Buy 150,909 3.75 565,908
2017-06-07 XENE Xenon Pharmaceuticals Inc. Buy 207,789 3.85 800,195
2017-06-05 NVLS Nivalis Therapeutics, Inc. Buy 35,750 2.29 81,903
2017-06-07 NVLS Nivalis Therapeutics, Inc. Buy 36,900 2.28 84,168
2017-05-31 NVLS Nivalis Therapeutics, Inc. Buy 28,100 2.25 63,140
2017-05-30 NVLS Nivalis Therapeutics, Inc. Buy 18,900 2.30 43,394
2017-05-17 NVLS Nivalis Therapeutics, Inc. Buy 37,372 2.30 85,918
2017-05-18 NVLS Nivalis Therapeutics, Inc. Buy 29,886 2.30 68,737
2017-05-19 NVLS Nivalis Therapeutics, Inc. Buy 11,600 2.30 26,679
2017-05-10 NVLS Nivalis Therapeutics, Inc. Buy 62,000 2.35 145,452
2017-05-11 NVLS Nivalis Therapeutics, Inc. Buy 7,034 2.34 16,480
2017-05-09 NVLS Nivalis Therapeutics, Inc. Buy 40,000 2.29 91,519
2017-01-03 INFI Infinity Pharmaceuticals, Inc. Buy 4,379 1.34 5,867
2016-12-30 INFI Infinity Pharmaceuticals, Inc. Buy 3,553 1.34 4,761
2016-12-28 INFI Infinity Pharmaceuticals, Inc. Buy 738,848 1.34 987,100
2016-12-20 INFI Infinity Pharmaceuticals, Inc. Buy 22,001 1.35 29,811
2016-12-19 INFI Infinity Pharmaceuticals, Inc. Buy 198,264 1.36 269,242
2016-12-16 INFI Infinity Pharmaceuticals, Inc. Buy 434,656 1.28 556,359
2016-12-01 INFI Infinity Pharmaceuticals, Inc. Buy 148,894 1.19 176,439
2016-12-02 INFI Infinity Pharmaceuticals, Inc. Buy 52,500 1.19 62,475
2016-01-07 CTIC Cell Therapeutics Inc Buy 633,780 1.22 771,310
2016-01-08 CTIC Cell Therapeutics Inc Buy 367,547 1.22 447,304
2014-12-17 ONTY Oncothyreon Inc. Buy 153,495 1.73 266,006
2014-12-15 ONTY Oncothyreon Inc. Buy 224,949 1.88 422,679
2014-03-24 LGND Ligand Pharmaceuticals Inc Sale 50,004 70.17 3,508,630
2014-03-25 LGND Ligand Pharmaceuticals Inc Sale 28,222 69.95 1,974,213
2014-02-27 PTN Palatin Technologies Inc Sale 293,825 1.09 320,269
2014-02-24 PTN Palatin Technologies Inc Sale 274,042 1.16 318,436
2014-02-25 PTN Palatin Technologies Inc Sale 220,742 1.12 247,231
2014-02-26 PTN Palatin Technologies Inc Sale 45,397 1.11 50,345
2014-02-20 LGND Ligand Pharmaceuticals Inc Sale 146,900 73.05 10,730,751
2014-02-19 LGND Ligand Pharmaceuticals Inc Sale 75,000 73.03 5,477,475
2014-02-18 LGND Ligand Pharmaceuticals Inc Sale 201,000 74.66 15,005,856
2014-02-14 PTN Palatin Technologies Inc Sale 29,032 1.16 33,706
2014-02-18 PTN Palatin Technologies Inc Sale 233,328 1.18 274,860
2014-02-19 PTN Palatin Technologies Inc Sale 43,606 1.11 48,489
2013-11-01 ONTY Oncothyreon Inc. Buy 129,000 1.78 229,620
2013-08-08 ONTY Oncothyreon Inc. Buy 258,361 1.65 426,295
2013-07-31 ONTY Oncothyreon Inc. Buy 179,743 1.71 307,360
2013-08-01 ONTY Oncothyreon Inc. Buy 158,344 1.78 282,327
2013-06-07 RIGL Rigel Pharmaceuticals Inc Buy 32,700 3.47 113,403
2013-06-07 ONTY Oncothyreon Inc. Buy 116,252 1.83 212,741
2013-06-05 ONTY Oncothyreon Inc. Buy 15,300 1.75 26,775
2013-06-06 ONTY Oncothyreon Inc. Buy 82,915 1.78 147,671
2012-11-07 TRGT Targacept Inc Buy 23,100 4.08 94,271
2012-11-08 TRGT Targacept Inc Buy 49,329 4.01 197,661
2012-11-06 CCXI Chemocentryx, Inc. Buy 40,000 12.00 479,840
2012-10-31 LGND Ligand Pharmaceuticals Inc Buy 4,076 14.99 61,095
2012-10-26 LGND Ligand Pharmaceuticals Inc Buy 12,515 15.26 190,928
2012-10-31 TRGT Targacept Inc Buy 52,000 4.06 210,912
2012-11-02 TRGT Targacept Inc Buy 57,600 4.05 233,452
2012-11-01 TRGT Targacept Inc Buy 30,100 4.05 121,814
2011-12-01 ARRY Array Biopharma Inc Buy 83,200 2.04 169,894
2011-12-02 ARRY Array Biopharma Inc Buy 32,100 2.10 67,377
2011-12-05 ARRY Array Biopharma Inc Buy 4,300 2.14 9,197
2011-11-23 ARRY Array Biopharma Inc Buy 64,253 2.21 142,063
2011-11-18 LGND Ligand Pharmaceuticals Inc Buy 72,669 11.01 799,795
2011-11-21 LGND Ligand Pharmaceuticals Inc Buy 438,371 10.59 4,642,348
2011-10-26 LGND Ligand Pharmaceuticals Inc Buy 6,020 13.91 83,750
2011-10-21 LGND Ligand Pharmaceuticals Inc Buy 4,600 13.93 64,064
2011-10-18 LGND Ligand Pharmaceuticals Inc Buy 2,200 13.73 30,214
2011-10-20 LGND Ligand Pharmaceuticals Inc Buy 11,900 13.93 165,814
2011-10-12 NBIX Neurocrine Biosciences Inc Buy 29,500 5.96 175,672
2011-10-12 LGND Ligand Pharmaceuticals Inc Buy 53,100 13.69 726,992
2011-10-13 LGND Ligand Pharmaceuticals Inc Buy 22,253 13.55 301,572
2011-10-10 NBIX Neurocrine Biosciences Inc Buy 70,100 5.59 391,718
2011-10-11 NBIX Neurocrine Biosciences Inc Buy 3,800 5.73 21,770
2011-10-04 LGND Ligand Pharmaceuticals Inc Buy 14,400 12.78 183,960
2011-09-07 ICGN Icagen Inc Buy 126,700 6.00 760,706
2011-09-06 CAPS Orthologic Corp Buy 312,900 .26 81,041
2011-08-19 CAPS Orthologic Corp Buy 38,900 .26 10,114
2011-08-22 CAPS Orthologic Corp Buy 8,800 .26 2,288
2011-08-18 CAPS Orthologic Corp Buy 31,200 .26 8,112
2011-08-19 LGND Ligand Pharmaceuticals Inc Buy 21,300 11.93 254,023
2011-08-18 LGND Ligand Pharmaceuticals Inc Buy 16,571 11.91 197,377
2011-08-11 LGND Ligand Pharmaceuticals Inc Buy 1,394 11.19 15,600
2011-08-10 LGND Ligand Pharmaceuticals Inc Buy 233,000 10.91 2,542,729
2011-08-09 LGND Ligand Pharmaceuticals Inc Buy 190,900 10.86 2,073,937
2011-08-08 LGND Ligand Pharmaceuticals Inc Buy 175,800 11.20 1,969,663
2011-07-26 CAPS Orthologic Corp Buy 18,400 .25 4,600
2011-07-20 CAPS Orthologic Corp Buy 252,600 .25 63,150
2011-07-14 CAPS Orthologic Corp Buy 19,700 .25 4,925
2011-07-18 CAPS Orthologic Corp Buy 338,900 .25 84,386
2011-07-11 CAPS Orthologic Corp Buy 9,000 .25 2,250
2011-06-30 CAPS Orthologic Corp Buy 4,700 .25 1,170
2011-06-29 CAPS Orthologic Corp Buy 12,950 .25 3,211
2011-06-28 CAPS Orthologic Corp Buy 30,400 .25 7,600
2011-06-27 CAPS Orthologic Corp Buy 56,700 .25 14,175
2011-05-17 CRA Celera Corp Buy 151,300 8.03 1,214,939
2011-05-13 CRA Celera Corp Buy 8,800 8.03 70,664
2011-05-16 CRA Celera Corp Buy 130,650 8.03 1,049,119
2011-05-10 CRA Celera Corp Buy 431,400 8.05 3,471,475
2011-05-11 CRA Celera Corp Buy 2,455,000 8.03 19,711,195
2011-05-12 CRA Celera Corp Buy 190,400 8.03 1,528,911
2011-05-09 CRA Celera Corp Buy 354,000 8.05 2,848,638
2011-05-06 CRA Celera Corp Buy 1,221,200 8.05 9,828,217
2011-05-05 CRA Celera Corp Buy 441,400 8.05 3,551,504
2011-05-04 CRA Celera Corp Buy 2,240,000 8.05 18,032,000
2011-04-20 CRA Celera Corp Buy 93,500 8.05 752,675
2011-04-21 CRA Celera Corp Buy 888,100 8.00 7,100,359
2011-04-20 CRA Celera Corp Buy 93,500 8.05 752,675
2011-04-21 CRA Celera Corp Buy 888,100 8.00 7,100,359
2011-04-15 CRA Celera Corp Buy 94,000 8.08 759,238
2011-04-19 CRA Celera Corp Buy 92,200 8.07 744,054
2011-04-14 CRA Celera Corp Buy 72,100 8.05 580,116
2011-04-13 CRA Celera Corp Buy 93,300 8.07 753,024
2011-04-12 CRA Celera Corp Buy 49,600 8.03 398,287
2011-04-08 CRA Celera Corp Buy 46,025 8.14 374,505
2011-04-07 CRA Celera Corp Buy 454,900 8.17 3,718,352
2011-04-11 CRA Celera Corp Buy 139,700 8.07 1,126,959
2011-04-05 CRA Celera Corp Buy 57,000 8.18 466,487
2011-04-06 CRA Celera Corp Buy 125,000 8.22 1,027,250
2010-04-20 SUPG Supergen Inc Sale 104,000 3.54 368,264
2010-04-19 SUPG Supergen Inc Sale 66,000 3.58 236,016
2010-04-19 SUPG Supergen Inc Sale 66,000 3.58 236,016
2010-04-20 SUPG Supergen Inc Sale 104,000 3.54 368,264
2010-04-05 ARQL Arqule Inc Sale 603,000 6.13 3,696,993
2010-04-01 ARQL Arqule Inc Sale 1,113,000 5.81 6,467,643
2010-03-31 ARQL Arqule Inc Sale 2,640,000 6.24 16,476,240
2009-09-22 ADLR Adolor Corp Sale 354,000 1.70 600,384
2009-09-17 ARQL Arqule Inc Sale 3,680,000 5.25 19,320,000
2009-09-21 ADLR Adolor Corp Sale 53,000 1.67 88,510
2009-09-17 ADLR Adolor Corp Sale 108,000 1.70 183,600
2009-09-18 ADLR Adolor Corp Sale 241,000 1.66 399,578
2009-09-16 ADLR Adolor Corp Sale 138,000 1.71 235,566
2009-09-14 ADLR Adolor Corp Sale 95,000 1.79 169,860
2009-09-15 ADLR Adolor Corp Sale 355,000 1.72 610,600
2009-07-13 ADLR Adolor Corp Sale 700,500 1.67 1,172,637
2009-07-14 ADLR Adolor Corp Sale 25,000 1.67 41,750
2009-06-19 ADLR Dynavax Technologies Corp Sale 21,500 2.00 42,978

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lampert Mark N ( of Infinity Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.